Azzam Bilal Chamdy

Johnson & Johnson Q2 2026: Balancing Robust Revenue Growth with Market Expectations

• Treatment Innovations

Johnson & Johnson Q2 2026: Balancing Robust Revenue Growth with Market Expectations

Azzam Bilal Chamdy July 18, 2026

Johnson & Johnson (J&J), the global healthcare conglomerate, has released its second-quarter financial results for 2026, painting...

Read More Read more about Johnson & Johnson Q2 2026: Balancing Robust Revenue Growth with Market Expectations

From Inspiration to Innovation: The Personal Journeys Shaping the Future of Genomics

• Genomics and Precision Medicine

From Inspiration to Innovation: The Personal Journeys Shaping the Future of Genomics

Azzam Bilal Chamdy July 17, 2026

The field of genomics represents the cutting edge of modern medicine, blending complex data analysis with the...

Read More Read more about From Inspiration to Innovation: The Personal Journeys Shaping the Future of Genomics

A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

• Genomics and Precision Medicine

A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

Azzam Bilal Chamdy July 17, 2026

The landscape of modern medicine has undergone a seismic shift. For thousands of patients in England suffering...

Read More Read more about A New Era in Medicine: CRISPR-Based Gene Therapy Casgevy Approved for NHS Patients

A Global Health Crisis: The Urgent Call for Equity in the Fight Against Cancer

• Breast Cancer Prevention and Lifestyle

A Global Health Crisis: The Urgent Call for Equity in the Fight Against Cancer

Azzam Bilal Chamdy July 16, 2026

The global community stands at a critical juncture in the fight against one of humanity’s most formidable...

Read More Read more about A Global Health Crisis: The Urgent Call for Equity in the Fight Against Cancer

Bridging the Data Gap: METAvivor Spearheads Push for Advanced Cancer Registry Reform

• Metastatic Breast Cancer Research

Bridging the Data Gap: METAvivor Spearheads Push for Advanced Cancer Registry Reform

Azzam Bilal Chamdy July 15, 2026

Introduction: A Critical Pivot in Oncology Data In the complex landscape of oncology research, data is the...

Read More Read more about Bridging the Data Gap: METAvivor Spearheads Push for Advanced Cancer Registry Reform

The Biological Vulnerability: Defining the Critical Postpartum Window for Breast Cancer Risk

• Clinical Oncology Education

The Biological Vulnerability: Defining the Critical Postpartum Window for Breast Cancer Risk

Azzam Bilal Chamdy July 15, 2026

New research from the UCLA Health Jonsson Comprehensive Cancer Centre has cast a significant light on the...

Read More Read more about The Biological Vulnerability: Defining the Critical Postpartum Window for Breast Cancer Risk

The Invisible Deficit: Why Biopharma’s Knowledge Gap Threatens the Future of Advanced Therapies

• Treatment Innovations

The Invisible Deficit: Why Biopharma’s Knowledge Gap Threatens the Future of Advanced Therapies

Azzam Bilal Chamdy July 15, 2026

In the high-stakes world of biopharmaceutical manufacturing, the most valuable asset is often the one that never...

Read More Read more about The Invisible Deficit: Why Biopharma’s Knowledge Gap Threatens the Future of Advanced Therapies

The Liquid Biopsy Revolution: Redefining Early-Stage Breast Cancer Surveillance Through MRD Testing

• Clinical Oncology Education

The Liquid Biopsy Revolution: Redefining Early-Stage Breast Cancer Surveillance Through MRD Testing

Azzam Bilal Chamdy July 15, 2026

The landscape of breast cancer management is undergoing a seismic shift. For decades, the standard of care...

Read More Read more about The Liquid Biopsy Revolution: Redefining Early-Stage Breast Cancer Surveillance Through MRD Testing

Beyond Pain Relief: Is Ibuprofen a Hidden Weapon Against Cancer?

• Medical Research and Clinical Trials

Beyond Pain Relief: Is Ibuprofen a Hidden Weapon Against Cancer?

Azzam Bilal Chamdy July 13, 2026

Ibuprofen, a ubiquitous presence in medicine cabinets worldwide, is a household name—the go-to remedy for everything from...

Read More Read more about Beyond Pain Relief: Is Ibuprofen a Hidden Weapon Against Cancer?

GSK’s Ris-Rez Breakthrough: A New Frontier in B7-H3 Targeted Cancer Therapy

• Treatment Innovations

GSK’s Ris-Rez Breakthrough: A New Frontier in B7-H3 Targeted Cancer Therapy

Azzam Bilal Chamdy July 10, 2026

In a landmark development for oncology, GSK has announced that its experimental antibody-drug conjugate (ADC), risvutatug rezetecan...

Read More Read more about GSK’s Ris-Rez Breakthrough: A New Frontier in B7-H3 Targeted Cancer Therapy